Abstract -The marine carotenoid fucoxanthin can be found in marine brown seaweeds, macroalgae, diatoms, and microalgae, and has remarkable biological properties. Numerous studies have shown that fucoxanthin has considerable potential and promising applications in human health, but the underlying mechanisms involved in its anti-allergic activity are not fully understood. We here investigated the mechanisms by anti-allergic activity of fucoxanthin fraction from Eisenia bicyclis in immunoglobulin E-antigen complex (IgE/DNP-BSA)-stimulated RBL-2H3 mast cells. This study we found that the fucoxanthin inhibits the release of β-hexosaminidase and suppressed not only transcriptional activation of NF-κB, but also phosphorylation of ERK and JNK in IgE/DNP-BSA-treated RBL-2H3 cells. Fucoxanthin may be useful for preventing allergic diseases, including asthma and atopic dermatitis.
Introduction
Mast cells and basophils play important roles initiating and perpetuating the inflammatory responses that mediate allergic reactions by secreting abundant levels of proinflammatory mediators such as histamine and several cytokines, including interleukin (IL)-4, IL-5, IL-13, and tumor necrosis factor (TNF)-α (Matsuda et al., 2008) . Because mast cells play essential roles in provoking the pathogenesis of allergic reactions via the degranulation process, measuring the degree of degranulation reflects the level of mast cell activation. β -Hexosaminidase released by these cells during this process has been reported to be a suitable marker for determining the degree of degranulation (Naal et al., 2004) . The rat basophilic leukemia cell line RBL-2H3, which expresses FcεRI, is widely used to study the molecular basis of mast cell activation (Huang et al., 2008) . This cell line has also been used to develop anti-allergy drugs that reduce allergic symptoms, including steroids that have anti-histamine actions and antiinflammatory drugs that inhibit cytokine production (Matsuda et al., 2008; Huang et al., 2008) . However, the effectiveness of such drugs is limited by their side effects. These problems have led to increasing interest in traditional herbal medicines that have been used to treat allergic diseases. As a result, more and more studies examining the efficacy of natural extracts and compounds isolated from natural extracts to prevent and treat allergic disorders are being performed.
Marine environment has been the source of diverse life forms that produce different biologically active compounds.
Metabolites from marine plants have been reported to have outstanding biological activities and profound applications in nutraceuticals, cosmeceuticals, and pharmaceuticals. Eisenia bicyclis is a species of the kelp, a member of the brown algae group of seaweeds, best known for its use in Asia. E. bicyclis is high in calcium, iodine, iron, magnesium, and vitamin A as well as being a good dietary source for many other minerals.
They also contain the storage polysaccharide laminarin, alginate, fucoxanthin and fucoidan with immunological activities (Joe et al., 2006) . It has been also known that brown algae extracts closely linked to its protective properties against free radical attack and have anti-oxidant, immunomodulatory effects (Hu et al., 2010; Kang et al., 2004; Namkoong et al., 2011) and numerous studies have shown that fucoxanthin has considerable potential and promising applications in human health (Peng Although E. bicyclis and its component, fucoxanthin have these biological activities, no reported study has evaluated the anti-allergic effect of E. bicyclis or fucoxanthin and the molecular mechanisms involved. Therefore, we examined the fucoxanthin ( Fig. 1) isolated from E. bicyclis on the antiallergic effects by checking the release of β-hexosaminidase induced by IgE/DNP-BSA in RBL-2H3 mast cells and the molecular mechanisms such as MAPKs-NF-κB activities, which are activated during allergic inflammation.
Materials and Methods

Preparation of fucoxanthin
The fronds of Eisenia bicyclis were harvested from the coast of Ulleung Island, East Sea, South Korea in June 2009. Fresh E. bicyclis was washed three times with tap water to remove salt and impurities, then dried at room temperature for 3 days and stored at -20℃. The dried samples were homogenized, using a grinder, before extraction. The fucoxanthin fraction was prepared by solvent partition method from the acetone extract of fresh E. bicyclis. Fucoxanthin fraction was used for CPC (centrifugal partition chromatography) using a two-phase solvent system of n-hexane-ethyl acetate-ethanolwater (5:5:7:3, v/v/v/v). The flow rate of mobile phase was 2 ml/min with descending mode while rotating at 1000 rpm.
The eluate was monitored at 410 nm. The content and structure of fucoxanthin in the CPC fraction were confirmed with HPLC, UV, APCI/MS and NMR spectra. A preparative CPC yielded 20 mg of fucoxanthin (87% recovery from fucoxanthin fraction) in a two-step separation from 516 mg of fucoxanthin fraction containing 4.59% fucoxanthin. The purity of the isolated fucoxanthin was about 81% in the first CPC step and over 95% in the second CPC step based on the calibration curve. This fucoxanthin was kindly provided by Dr. Um (Natural Product Research Center, KIST Gangneung Institute, Korea) (Kim et al., 2011) .
Cell culture
The RBL-2H3 rat mast cell line, HaCaT human keratinocyte cell line, NIH3T3 mouse fibroblast cell line were obtained from the American Type Culture Collection (Rockville, MD) and grown in minimum essential medium (MEM) with 15% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37℃ in a humidified incubator with a 5% CO2 / 95% air atmosphere.
Reagents
The anti-dinitrophenyl (DNP)-IgE and 4-nitrophenyl Nacetyl-β-D-glucosaminide were from Sigma-Aldrich, DNPbovine serum albumin (BSA) was from Biosearch Technologies, minimum essential medium was from Invitrogen, fetal bovine serum (FBS) was from WelGENE, the protein assay kit was from BioRad Laboratories, anti-pERK, anti-ERK, anti-pJNK, anti-JNK, and anti-p-p38 were from Cell Signaling Technology, anti-p65 and anti-p38 were from Santa Cruz Biotechnology, anti-β-actin was from Sigma-Aldrich, anti-α-tubulin was from Abfrontier, the ECL chemiluminescence system was from GE Healthcare, and the polyvinylidene difluoride (PVDF) membrane was from Millipore.
XTT assay for cell survivability
Cell survivability was examined using the XTT assay kit, 
Nitrite determination
Cells were incubated in either medium alone or medium supplemented for 24 h and the accumulation of nitrite in culture supernatants was measured using the assay system described by Ding et al. (1988) . One hundred micro litter aliquots of culture supernatants were mixed with an equal volume of Griess reagent (mixture at 1:1 of naphthylethylenediamine dihydrochloride and 1% sulphanilamide in 5% H3PO4) and incubated at room temperature for 10 min. Nitrite concentration was calculated from a NaNO2 standard curve.
β -Hexosaminidase release assay
Degranulation of RBL-2H3 cells was evaluated by measuring the activity of the granule-stored enzyme-β-hexosaminidase secreted in the extracellular medium. Cells were cultured in 24-well plates (2×10 5 cells/well) overnight. The cells were sensitized with anti-DNP-IgE (100 ng/ml) for 16 h at 37℃.
After washing the cells with TGCM buffer (136 mM NaCl, 2.68 mM KCl, 0.36 mM NaH2PO2·H2O, 1 mM CaCl2, 0.5 mM MgCl2, 11.9 mM NaHCO3, 5 mM dextrose, 1 g/L gelatin, pH 7.4), they were pretreated with fucoxanthin (0.1, 1, and 10 μg/ml) for 30 min and then treated with DNP-BSA (1 μg/ml) 
Western blotting
Total cell lysates were plated at 3×10 7 cells/ml and treated with fucoxanthin (0.1, 1, and 10 μg/ml) and DNP-BSA (0.01 μg/ml) for 15 min and then harvested and lysed in a lysis buffer containing 20 mM Tris, pH 7.6, 150 mM NaCl, and 1%
Triton X-100 with a protease inhibitor cocktail. Protein contents were measured using a protein assay kit (Bio-Rad).
Samples were diluted with 1× lysis buffer containing 1% β -mercaptoethanol. Equal amounts of cellular protein (50 μg)
were resolved by 10% SDS-PAGE and transferred onto nitrocellulose membranes. After blocking, membranes were incubated with the target antibody and then with horseradish peroxidase-conjugated secondary antibody to IgG. Immunoreactive proteins were visualized using the ECL Western blot detection system. The protein level was compared to a loading control, such as β-actin or non-phosphorylated protein.
Subcellular fractionation
Cytosolic and nuclear extracts were prepared. In brief, RBL-2H3 cells (5×10 6 cells/ml) were plated into 100 mm dishes and treated with fucoxanthin (0.1, 1, and 10 μg/ml) and IgE/DNP-BSA (0.01 μg/ml) for 4 h. The harvested cells were resuspended in 0.2 ml of buffer A (10 mM HEPES at pH 7.5, 
Statistical analyses
Each experiment was repeated three or four times, and the results of a representative experiment are shown. The results are expressed as the means±SEM and were compared using Student's t-test. A statistical probability of p < 0.05 was considered significant (# p < 0.05, ## p < 0.01, * p < 0.05, and ** p < 0.01).
Results and Discussion
Traditional medicines isolated from natural products often have positive effects in the prevention and healing of various immune disorders, such as allergy and atopic inflammation. Fucoxanthin at concentrations ranging from 0.1-10 μg/ml did not significantly affect the cytotoxicity in 24 h ( Fig. 2A) .
Thus, we treated DNP-IgE-sensitized RBL-2H3 cells with fucoxanthin ranging from 0.1-10 μg/ml in subsequent experiments. Fucoxanthin significantly suppressed the DNP-BSA induced β-hexosaminidase secretion in IgE-sensitized RBL-2H3 cells at 1 and 10 μg/ml and the effects are dose-dependent (Fig. 2B) . Ketotifen fumarate, an anti-allergic drug, also decreased the β-hexosaminidase secretion. The results showed that fucoxanthin significantly inhibited antigen-induced mast cell degranulation.
Atopic dermatitis is characterized by allergic skin inflammation. Pathological changes in atopic skin are observed as epidermal thickening and marked infiltration of inflammatory cells (Soter, 1989) . Here, we evaluated the effects of fucoxanthin on the allergic skin diseases using the kinetic proliferation and the regulation of NO production in human keratinocytes (HaCaT) and mouse fibroblast (NIH3T3) cells (Park et al., 2010) , but fucoxanthin has no significant effects ( and nuclear (N-) fraction, the translocation of NF-κB (p65) was assessed by Western blotting described in methods respectively.
antigen treatments. In contrast, the relative intensity of NF-κ B (p65) translocation in the nucleus was decreased considerably, to the control basal level, after the addition of 10 μg/ ml fucoxanthin. These data demonstrate that fucoxanthin attenuated NF-κB activation and might affect the degranulation of histamine in mast cells.
NF-κB is a key transcription factor that regulates the expression of genes involved in immune and inflammatory responses that require inflammatory cytokine production.
NF-κB translocation and the MAPKs pathway are regarded as important processes in the regulation of the innate and acquired immune responses and chronic allergic inflammation (Karin and Lin, 2002; Barnes, 2008) . NF-κB is also a critical transcription factor that regulates Th2 cell differentiation and Th2-dependent airway inflammation in asthma (Yang et al., 1998) . Increased NF-κB activity has been reported in asthma, an allergic disease, and the inhibition of NF-κB activity decreased asthma (Barnes, 2008) . Thus, we suggest that fucoxanthin could have an anti-allergic effect based on the decrease in activated NF-κB it causes.
Conventional MAP kinases are classified into three families: the c-Jun N-terminal kinases (JNKs), the p38 MAP kinases, and the extracellular signal-regulated kinases (ERKs). Intracellular signal transduction, including the phosphorylation of p38 MAPK, is subsequently followed by NF-κB translocation, leading to the production of cytokines and chemokines.
We also showed that fucoxanthin significantly suppressed the IgE/DNP-BSA-activated phosphorylation of ERK and JNK but not p38 in RBL-2H3 mast cells (Fig. 6 ). It has been reported that MAPK activation can activate transcription factors that result in the expression of IL-4, IL-5, and IL-13 in human T cells in response to antigen exposure in allergic disease (Barnes, 2008) . Recently, Lee et al. (2012) reported that the glycoprotein isolated from Cudrania tricuspidata inhibits release of β-hexosaminidase via down regulation of MAPK/NF-κB on the stage of mast cell degranulation.
We found here that fucoxanthin may exert inhibitory effects on the antigen-induced degranulation by suppressing the transcription of NF-κB and the activation of ERK-JNK but not of p38 in signaling pathways. From these results, we suggest that fucoxanthin might be useful as a therapeutic agent for treating various forms of allergic inflammation, including asthma and atopic dermatitis.
